Due Diligence & Transaction Advisory
Despite everything, SNF transaction volume is considerable. As competition mounts, operators and investors are increasingly seeking opportunities, often in unfamiliar locales. This reach poses unique challenges when assessing the long-term value-proposition of the asset.
ZHSG serves post-acute care providers in nearly 40 states, and our team studies the distinct nuances of every new market we enter. Our Transaction Advisory protocols go far beyond routine “Due Diligence.” Our proprietary “State Outlook Assessment” is supported by detailed analytics and updated quarterly. We meticulously forecast the impact of state and federal payment trends, managed care advancement, audit risk, area age / disease demographics, hospital discharge patterns, competitor landscape, labor pool, market saturation and other advanced metrics to identify opportunities that others cannot discern.
ZHSG is also able to facilitate capital financing through our partnership with Greystone, a real estate lending, investment and advisory company. Zimmet Healthcare’s President & CEO Marc Zimmet serves as a Managing Director in Greystone’s healthcare lending group. This relationship creates a comprehensive solution for even the most challenging transaction, with an unmatched level of support that continues long after the deal is closed.
